SEC Form D · filed July 6, 2022
Prellis Biologics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Michael Marks · Hayward, CADirectorMelanie Matheu · Hayward, CAExec · DirectorAlex Morgan · Hayward, CADirectorShaun Holt · Hayward, CADirectorJoseph A. Bergida · Olathe, KSExec · DirectorJohn R. Bergida · Ballwin, MODirectorMichael Blady · Vancouver, British Columbia, CanadaDirectorDuane Lo · Vancouver, British Columbia, CanadaDirectorSean O'Sullivan · Hayward, CADirectorLei Meng · Hayward, CADirectorJack T. Conti · Richmond, VADirectorAshwini S. Obulreddygari · Frisco, TXDirectorMichael Malafronte · New York, NYDirectorBrian J. O'Connor · New York, NYExec · DirectorSean O'Sullivan · Hayward, CADirectorLei Meng · Hayward, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗